MIL:1CRL's Days Payable is ranked worse than 89.53% of 191
companies
in the Medical Diagnostics & Research industry
Industry Median: 65.09
vs MIL:1CRL: 20.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International Days Payable Chart
Charles River Laboratories International Annual Data
MIL:1CRL vs RVTY, QGEN, ICLR: Days Payable Comparison
For the Diagnostics & Research subindustry, Charles River Laboratories International's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charles River Laboratories International Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Days Payable distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's Days Payable falls into.
Charles River Laboratories International Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (MIL:1CRL) has a Days Payable of 18.28 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Charles River Laboratories International and its competitors. This is 17% below median its historical median of 21.92. Over the past decade, Charles River Laboratories International's Days Payable has ranged from 18.44 to 29.34. According to the industry distribution chart, Charles River Laboratories International ranks #171 out of 191 companies in the Medical Diagnostics & Research industry, placing it in the top 89.5%.
Is Charles River Laboratories International's Days Payable too high?
Charles River Laboratories International's current Days Payable of 18.28 is 17% below median its 10-year median of 21.92. Over the past 10 years, this metric has ranged from a low of 18.44 to a high of 29.34. The Medical Diagnostics & Research industry median Days Payable is 65.09. Charles River Laboratories International's value of 18.28 is 71.9% below this industry median. Based on the distribution chart, Charles River Laboratories International ranks #171 out of 191 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Charles River Laboratories International has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Days Payable compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #171 out of 191 companies for Days Payable. This places Charles River Laboratories International in the lower half of its industry. The industry median Days Payable is 65.09. Charles River Laboratories International's value of 18.28 is 71.9% below this benchmark. Historically, Charles River Laboratories International's own Days Payable has ranged from 18.44 to 29.34 over the past decade. While the company's 10-year median is 21.92 vs. the industry median of 65.09, Charles River Laboratories International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 65.09, based on 191 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Charles River Laboratories International's current Days Payable of 18.28 is 71.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Charles River Laboratories International and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 65.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Charles River Laboratories International's current Days Payable is 18.28, which is 17% below median its own 10-year median of 21.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Days Payable of 18.28. The stock's GF Value™ is €121.29, compared to a current price of €143.90 — trading 18.6% above its estimated fair value. The current Days Payable is 18.28, which is 17% below median its 10-year median of 21.92 and 71.9% below the Medical Diagnostics & Research industry median of 65.09. Charles River Laboratories International's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Days Payable is 18.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?
Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued.
The current stock price of €143.90 is trading 18.6% above its estimated GF Value™ of €121.29.
Key valuation signals for MIL:1CRL:
Days Payable: 18.28 (17% below median its 10-year median of 21.92)
GF Value™: €121.29 vs. price of €143.90 (18.6% above fair value)
Industry Position: 71.9% below the Medical Diagnostics & Research median (#171 of 191)
No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Charles River Laboratories International Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score
Get the complete analysis for MIL:1CRL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1CRL has been successfully added to your 
